Gertrude Biomedical
PrivateMomentum
Top 50%
of companies Caplight tracks
Company Overview
Gertrude Biomedical operates in Healthcare & Life Sciences and is based in Parkville. It was founded in 2019.
Gertrude Biomedical is a biotechnology company that develops small-molecule inhibitors targeting transcription factors, such as SOX18, to treat various cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gertrude Biomedical Comparables
Compare Gertrude Biomedical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Reglagene | 82% | |
| Flare Therapeutics | 78% | |
| Kronos Bio | 70% |
For institutional investors. Book with your work email.
Gertrude Biomedical Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 19, 2026
Monthly visitors increased 43% MoM.
- Oct 27, 2024
Monthly visitors grew 60% MoM, reaching 1.6K.
For institutional investors. Book with your work email.
Gertrude Biomedical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Gertrude Biomedical's valuation, stock price, and market status.
Is Gertrude Biomedical a public or private company?
Gertrude Biomedical is a private company.
What is the current stock price of Gertrude Biomedical?
Gertrude Biomedical is a private company, so its shares have no public market price. Caplight tracks Gertrude Biomedical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Gertrude Biomedical worth (valuation)?
Valuation information for Gertrude Biomedical is not publicly available.
Can I buy Gertrude Biomedical stock?
Gertrude Biomedical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Gertrude Biomedical's last funding round?
Funding round information for Gertrude Biomedical is not publicly available.
Who are the main investors in Gertrude Biomedical?
Investor information for Gertrude Biomedical is not publicly disclosed.
Will Gertrude Biomedical IPO soon?
No public IPO plans have been announced for Gertrude Biomedical.
How can I track Gertrude Biomedical secondary market activity?
Caplight tracks bids, offers, and trades in Gertrude Biomedical's shares on secondary markets.